Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 14:12:273-285.
doi: 10.2147/PGPM.S179172. eCollection 2019.

Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges

Susanne B Haga  1
Affiliations

Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges

Susanne B Haga. Pharmgenomics Pers Med. .

Abstract

For the past several years, the implementation of pharmacogenetic (PGx) testing has become widespread in several centers and clinical practice settings. PGx testing may be ordered at the point-of-care when treatment is needed or in advance of treatment for future use. The potential benefits of PGx testing are not limited to adult patients, as children are increasingly using medications more often and at earlier ages. This review provides some background on the use of PGx testing in children as well as mothers (prenatally and post-natally) and discusses the challenges, benefits, and the ethical, legal, and social implications of providing PGx testing to children.

Keywords: benefit; children; consent; education; maternal health; pharmacogenetic testing; risk.

PubMed Disclaimer

Conflict of interest statement

Dr Susanne B Haga reports grants from US National Institutes of Health, during the conduct of the study. The author reports no other conflicts of interest in this work.

Similar articles

See all similar articles

Cited by

References

    1. Aka I, Bernal CJ, Carroll R, Maxwell-Horn A, Oshikoya KA, Van Driest SL. Clinical pharmacogenetics of cytochrome P450-associated drugs in children. J Pers Med. 2017;7:14. doi:10.3390/jpm7040014 - DOI - PMC - PubMed
    1. Lee SHR, Yang JJ. Pharmacogenomics in acute lymphoblastic leukemia. Best Pract Res Clin Haematol. 2017;30:229–236. doi:10.1016/j.beha.2017.07.007 - DOI - PubMed
    1. Moriyama T, Relling MV, Yang JJ. Inherited genetic variation in childhood acute lymphoblastic leukemia. Blood. 2015;125:3988–3995. doi:10.1182/blood-2014-12-580001 - DOI - PMC - PubMed
    1. Cheok MH, Pottier N, Kager L, Evans WE. Pharmacogenetics in acute lymphoblastic leukemia. Semin Hematol. 2009;46:39–51. doi:10.1053/j.seminhematol.2008.09.002 - DOI - PMC - PubMed
    1. Lancia P, Adam de Beaumais T, Elie V, et al. Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus. Pediatr Nephrol. 2018;33:1045–1055. doi:10.1007/s00467-017-3881-3 - DOI - PubMed